These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12841198)
21. [Therapeutic update 1997-1998 (1). First part]. Scheen AJ Rev Med Liege; 1998 Aug; 53(8):459-66. PubMed ID: 9810205 [TBL] [Abstract][Full Text] [Related]
22. Synthetic biologists spring into action at the 245th American Chemical Society National Meeting. Glasgow JE; Tullman-Ercek D ACS Synth Biol; 2013 Jun; 2(6):293-5. PubMed ID: 24884108 [TBL] [Abstract][Full Text] [Related]
23. Evolution of solid-state NMR in pharmaceutical analysis. Vogt FG Future Med Chem; 2010 Jun; 2(6):915-21. PubMed ID: 21426109 [TBL] [Abstract][Full Text] [Related]
24. Ontologies of drug discovery and design for neurology, cardiology and oncology. Vázquez-Naya JM; Martínez-Romero M; Porto-Pazos AB; Novoa F; Valladares-Ayerbes M; Pereira J; Munteanu CR; Dorado J Curr Pharm Des; 2010; 16(24):2724-36. PubMed ID: 20642429 [TBL] [Abstract][Full Text] [Related]
25. American Heart Association--scientific sessions 2004. Drug highlights II. 7-10 November 2004, New Orleans, LA, USA. Dalziel C IDrugs; 2004 Dec; 7(12):1088-9. PubMed ID: 15599800 [No Abstract] [Full Text] [Related]
26. The 6th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology (PBP meeting) April 7-10, 2008, Barcelona, Spain. Kleinebudde P; Alex R; Fattal E; Göpferich A; Siepmann J AAPS PharmSciTech; 2008; 9(3):828. PubMed ID: 18618267 [No Abstract] [Full Text] [Related]
28. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing. Rantanen J; Khinast J Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754 [No Abstract] [Full Text] [Related]
29. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products; safety considerations related to extractables and leachables. Jenke D J Pharm Sci; 2007 Oct; 96(10):2566-81. PubMed ID: 17701994 [TBL] [Abstract][Full Text] [Related]
30. Guiding molecules towards drug-likeness. Egan WJ; Walters WP; Murcko MA Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312 [TBL] [Abstract][Full Text] [Related]
31. Role of nanotechnology in developing new therapies for diseases of the nervous system. Jain KK Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203 [No Abstract] [Full Text] [Related]
32. [Application of high-throughput technologies in pharmaceutics]. Bai XL; Gao YL Yao Xue Xue Bao; 2006 Jun; 41(6):487-92. PubMed ID: 16927820 [No Abstract] [Full Text] [Related]
34. Overview on Therapeutic Applications of Microparticulate Drug Delivery Systems. Bale S; Khurana A; Reddy AS; Singh M; Godugu C Crit Rev Ther Drug Carrier Syst; 2016; 33(4):309-361. PubMed ID: 27910739 [TBL] [Abstract][Full Text] [Related]
35. American Chemical Society--229th National Meeting. Mackonochie M; Chan D IDrugs; 2005 Apr; 8(4):277-9. PubMed ID: 15800794 [No Abstract] [Full Text] [Related]
36. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances. Reutzel-Edens SM Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688 [TBL] [Abstract][Full Text] [Related]
37. American Physiological Society Fall scientific meeting. October 15-19, 1979. New Orleans, Louisiana. Abstracts. Physiologist; 1979 Aug; 22(4):1-140. PubMed ID: 42937 [No Abstract] [Full Text] [Related]
39. Medical therapy for the patient with obesity. Bray GA; Ryan DH Circulation; 2012 Apr; 125(13):1695-703. PubMed ID: 22474312 [No Abstract] [Full Text] [Related]
40. Abstracts of papers. Society of Toxicology. Eighteenth annual meeting. New Orleans, Louisiana. March 11--15, 1979. Toxicol Appl Pharmacol; 1979 Mar; 48(1 Pt 2):A1-206. PubMed ID: 36688 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]